August 22nd, 2012
Abbott cholesterol drug subject of false-marketing suit
By Peter Frost
A former Abbott Laboratories saleswoman has filed a federal lawsuit against the company, accusing it of illegally promoting its cholesterol drug TriCor for uses not approved by regulators, including the prevention of cardiac health risks in patients with diabetes.
The suit was filed in September 2009 in U.S. District Court in the Eastern District of Pennsylvania by Amy Bergman. It was filed under the False Claims Act on behalf of the federal government, 22 states andWashington, D.C.
It was previously confidential under laws designed to protect would-be whistle-blowers who come forward with information about alleged health care fraud, but it was unsealed last week after federal and state governments declined to intervene.